Quincy Bioscience is a research-based biotechnology company
Quincy Bioscience is a biotechnology company based in Madison, Wis. that focuses on the discovery, development and commercialization of novel technologies to support cognitive function and other normal health challenges such as mild memory loss associated with aging.
Quincy Bioscience is set apart by its cutting-edge applications of apoaequorin which is breaking new ground in protecting brain cells against aging. Apoaequorin is a calcium-binding protein originally discovered in jellyfish, now patented by Quincy Bioscience for use in a variety of products to support cognitive function. Apoaequorin is manufactured in a cGMP compliant facility.
The discovery and development of apoaequorin in 1962 as a calcium signaler earned the scientists responsible the Nobel Prize in Chemistry in 2008. Quincy Bioscience is building on this work through its novel use of the protein. Apoaequorin achieved self-affirmed GRAS status (generally recognized as safe) after an independent panel of expert scientists concluded that apoaequorin is safe for use in food products.
Prevagen® is the company’s flagship consumer brand containing apoaequorin which has shown in published studies to be safe and effective. A landmark double-blind and placebo-controlled trial demonstrated Prevagen improved short-term memory, learning, and delayed recall over 90 days.
As a result of the supplement’s safety and effectiveness, Prevagen is now the best-selling brain health supplement in chain pharmacies across America according to Nielsen data.
In 2013, Quincy Bioscience was included in the Inc. 500|5000 list of the fastest growing private companies in the nation, for the second consecutive year.
Prevagen is 100% manufactured in the United States
Apoaequorin is no longer extracted from the jellyfish. The protein can be grown in a controlled scientific process. The end result is the exact composition of apoaequorin without any of the heavy metal pollution that jellyfish may be exposed to in the ocean. Additionally, all phases of production are conducted in the state of Wisconsin.
Quincy Bioscience’s Quality Assurance Department is fully compliant with current Good Manufacturing Practice (cGMP) standards as defined in federal code by 21 CFR 111. All batches are tested for purity, strength and safety.